D-dimer for efficacy prediction in COVID-19 patients treated with paxlovid
Our findings suggested that the reduced efficacy of paxlovid could be predicted by elevated D-dimer levels in COVID-19 patients.
Authors
- Wenrui Lin
- Yanli Xie (ORCID: https://orcid.org/0000-0002-3895-5959)
- Qingrong Wu
- Daishi Li (ORCID: https://orcid.org/0000-0002-1987-6577)
- Furong Zeng (ORCID: https://orcid.org/0000-0001-6621-8131)
Institutions
- Central South University (CN)
- SKiN Health (CA)
- Hunan Cancer Hospital (CN)
- Education Department of Hunan Province (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1186/s12879-024-10254-x
- Primary Topic
- Hematological disorders and diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China